For the Inventor, By the Inventor

Enter assignee name

Ness Ziona, Israel

Amorphical Ltd.

USPTO Granted Patents = 20

CIPO Patents = 1

EPO Patents = 10

Trademarks = 2

Forward Citations = 17

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Yosef Ben (12 out of 13 patents)

Yigal Dov Blum (9 out of 39 patents)

Abraham Shahar (4 out of 4 patents)

4. Amir Arav (4 out of 12 patents)

5. Assaf Shechter (4 out of 7 patents)

6. Amir Sagi (4 out of 12 patents)

7. Oren Meiron (4 out of 4 patents)

8. Sharon Hershkovitz (3 out of 3 patents)

9. Hagay Moshe (2 out of 2 patents)

10. Ben Ashkenazi (2 out of 2 patents)

11. Galit Shaltiel-Gold (2 out of 2 patents)

12. Michal Daniely (2 out of 2 patents)

13. Shmuel Bentov (2 out of 2 patents)

14. Amir Berman (2 out of 3 patents)

15. Binyamin Ashkenazi (2 out of 2 patents)

20 patents: Sort by Forward Citations

1. 12714726 - Encapsulated amorphous calcium carbonate compositions (2026-08-25),

2. 12629390 - Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions (2026-05-19),

3. 12357656 - Amorphous calcium carbonate for improving athletic performance (2025-07-15),

4. 12121538 - Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration (2024-10-22),

5. 12115184 - Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates (2024-10-15),

6. 12060573 - Stabilized amorphous calcium carbonate as a supplement for cell culture media (2024-08-13),

7. 11602542 - Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate (2023-03-14),

8. 11446327 - Encapsulated amorphous calcium carbonate compositions (2022-09-20),

9. 11207347 - Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions (2021-12-28),

10. 11052108 - Amorphous calcium carbonate for treating a leukemia (2021-07-06),

11. 11052107 - Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates (2021-07-06),

12. 11033576 - Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration (2021-06-15),

13. 10758566 - Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions (2020-09-01),

14. 10758565 - Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration (2020-09-01),

15. 10688124 - Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders (2020-06-23),

Amorphical Ltd. is a biopharmaceutical company focused on the research, development, and commercialization of innovative treatments for osteoporosis and related bone disorders. With a commitment to improving the lives of patients, Amorphical leverages its proprietary technology to develop novel calcium-based drugs that have the potential to revolutionize bone health. Through strategic partnerships and collaborations, Amorphical aims to make a lasting impact in the field of osteoporosis therapy.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

20 Patents

#4 in Ness Ziona

#303 in Israel

#31,162 in the World

Ness Ziona, Israel

Amorphical Ltd.

Forward Citations = 17

18 inventors:

Yosef Ben (12 out of 13 patents)

Yigal Dov Blum (9 out of 39 patents)

Abraham Shahar (4 out of 4 patents)

4. Amir Arav (4 out of 12 patents)

5. Assaf Shechter (4 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…